- 1) Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo Jr., J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright Jr., J. T., and Roccella, E. J., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: JNC 7 report. JAMA, 289, 2560–2572 (2003).
- 2) Yokoyama, K., Chiba, H., and Yoshikawa, M., Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci. Biotechnol. Biochem., 56, 1541–1545 (1992).
- 3) Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., and Osajima, Y., Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci. Biotechnol. Biochem., 58, 2244–2245 (1994).
- 4) Eto, Y., Ito, T., and Nishioka, S., Angiotensin I converting enzyme-inhibitory dipeptides in an alkaline protease hydrolyzate of whey protein. Nippon Eiyou Shokuryo Gakkaisi (in Japanese), 51, 355–359 (1998).
- 5) Kawamura, Y., Angiotensin converting enzyme inhibitory peptides and depressive effect of blood pressure in soy bean protein. Shokuhin Kogyo (in Japanese), 40, 73–82 (1997).
- 6) Kang, M. H., Kawai, Y., Naito, M., and Osawa, T., Dietary defatted sesame flour decreases susceptibility to oxidative stress in hypercholesterolemic rabbits. J. Nutr., 129, 1885–1890 (1999).
- 7) Utsunomiya, T., Chavali, S. R., Zhong, W. W., and Forse, R. A., Effects of sesamin-supplemented dietary fat emulsions on the ex vivo production of lipopolysaccharide-induced prostanoids and tumor necrosis factor alpha in rats. Am. J. Clin. Nutr., 72, 804–808 (2000).
- 8) Nakano, D., Itoh, C., Ishii, F., Kawanishi, H., Takaoka, M., Kiso, Y., Tsuruoka, N., Tanaka, T., and Matsumura, Y., Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Biol. Pharm. Bull., 26, 1701–1705 (2003).
- 9) Ochi, S., Mori, T., Horikawa, M., Mikami, H., and Sato, M., Angiotensin converting enzyme inhibitory peptides from sesame protein. Nihon Nougeikagakukai Taikai Koen Yoshi-shu (in Japanese), p. 142 (1995).
- 10) Ochi, S., Mori, T., Horikawa, M., Mikami, H., and Sato, M., Japan Kokai Tokkyo Koho, P3135812 (Dec. 25, 2002).
- 11) Friedland, J., and Silverstein, M. D., A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am. J. Clin. Pathol., 66, 416–424 (1976).
- 12) Lineweaver, H., and Burk, D., The determination of enzyme dissociation constants. J. Am. Chem. Soc., 56, 658–666 (1934).
- 13) Dixon, M., The determination of enzyme inhibitor constants. Biochem. J., 55, 170–171 (1953).
- 14) Masuda, O., Nakamura, Y., and Takano, T., Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr., 126, 3063–3068 (1996).
- 15) Nakamura, Y., Yamamoto, N., Sakai, K., and Takano, T., Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors of angiotensin I-converting enzyme. J. Dairy Sci., 78, 1253–1257 (1995).
- 16) Matsui, T., Li, C. H., Tanaka, T., Maki, T., Osajima, Y., and Matsumoto, K., Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol. Pharm. Bull., 23, 427–431 (2000).
- 17) Matsui, T., Hayashi, A., Tamaya, K., Matsumoto, K., Kawasaki, T., Murakami, K., and Kimoto, K., Depressor effect induced by dipeptide, Val-Tyr, in hypertensive transgenic mice is due, in part, to the suppression of human circulating renin-angiotensin system. Clin. Exp. Pharmacol. Physiol., 30, 262–265 (2003).
- 18) Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S., and Tanaka, T., Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci., 78, 777–783 (1995).
- 19) Matsui, T., Li, C. H., and Osajima, Y., Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J. Pept. Sci., 5, 289–297 (1999).
- 20) Miyosi, S., Ishikawa, H., Kaneko, T., Fukui, F., Tanaka, H., and Maruyama, S., Structures and activity of angiotensin-converting enzyme inhibitors in an α-zein hydrolyzate. Agric. Biol. Chem., 55, 1313–1318 (1991).
- 21) Takane, S., and Satake, S., Japan Kokai Tokkyo Koho, H3-81291 (Apr. 5, 1991).
- 22) Cheng, S., Wang, F., Ondetti, M. A., Sabo, E. F., and Cushman, D. W., Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. J. Biol. Chem., 255, 401–407 (1980).
- 23) Hara, H., Funabiki, R., Iwata, M., and Yamazaki, K., Portal absorption of small peptides in rats under unrestrained condition. J. Nutr., 114, 1122–1129 (1984).
- 24) Adibi, S. A., Interstitial transport of dipeptides in man: relative importance of hydrolysis and intact absorption. J. Clin. Invest., 50, 2266–2275 (1971).
- 25) Ririe, D. G., Roberts, P. R., Shouse, M. N., and Zaloga, G. P., Vasodilatory actions of the dietary peptide carnosine. Nutrition, 16, 168–172 (2000).
- 26) Takai, S., Jin, D., Sakaguchi, M., and Miyazaki, M., Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. Hypertens. Res., 27, 213–219 (2004).
- 27) Murakami, T., Soga, M., Mitsunaga, T., Yoshizumi, H., and Ito, H., The vascular tissue angiotensin I-converting enzyme activity and aortic elastin content in stroke-prone spontaneously hypertensive rats fed a fish diet. Clin. Exp. Pharmacol. Physiol., 21, 453–461 (1994).
Bioscience, Biotechnology, and Biochemistry
Volume 70, 2006 - Issue 5